• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study
CONCLUSION: Patients with T2DM represent almost half of patients with CRS and are younger than their non-diabetic counterparts. T2DM doubles the risk of CRS and increases the risk of death, cardiovascular outcome, and end-stage kidney disease but not ischemic stroke after CRS.PMID:36931430 | DOI:10.1016/j.diabet.2023.101441
Source: Diabetes and Metabolism - March 17, 2023 Category: Endocrinology Authors: Valentin Maisons Jean-Michel Halimi Gr égoire Fauchier Jean-Baptiste de Fr éminville Nicolas Goin Juliette Gueguen Philippe Gatault B énédicte Sautenet Denis Angoulvant Julien Herbert Arnaud Bisson Pierre-Henri Ducluzeau Laurent Fauchier Source Type: research

Prevalence and Incidence of Cardiovascular and Renal Diseases in Type 1 Compared with Type 2 Diabetes: A Nationwide French Observational Study of Hospitalized Patients
CONCLUSIONS: Although the crude prevalent burden of CV diseases may be lower in T1DM than in T2DM, patients with T1DM may have a higher risk of incident MI, HF, all-cause death and CV death above 60 years of age, highlighting the need for improved prevention in this population.PMID:36736892 | DOI:10.1016/j.diabet.2023.101429
Source: Diabetes and Metabolism - February 3, 2023 Category: Endocrinology Authors: Pierre Henri Ducluzeau Gr égoire Fauchier Julien Herbert Carl Semaan Jean Michel Halimi Denis Angoulvant Laurent Fauchier Source Type: research

Antidiabetic agents and risk of atrial fibrillation/flutter: a comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists
Diabetes Metab. 2022 Sep 25:101390. doi: 10.1016/j.diabet.2022.101390. Online ahead of print.ABSTRACTAtrial fibrillation/flutter (AF/AFL) is a common cardiac arrhythmia in patients with diabetes and is associated with an increased risk of morbidity, including ischaemic stroke and heart failure, and mortality. Different classes of glucose-lowering agents have shown distinct effects on the risk of stroke and heart failure. Their effects on cardiac arrhythmias such as AF/AFL have not been carefully investigated yet and even less their possible relationship with classical complications such as stroke and heart failure. The pre...
Source: Diabetes and Metabolism - September 28, 2022 Category: Endocrinology Authors: Andr é J Scheen Source Type: research

Pages: 1  2